Industry Research Reports

Home > Reports > Chemical & Material > Global Cosmetic Grade Nicotinamide Mononucleotide Market Outlook, In‑Depth Analysis & Forecast to 2031

Global Cosmetic Grade Nicotinamide Mononucleotide Market Outlook, In‑Depth Analysis & Forecast to 2031

Industry: Chemical & Material

Published Date: 2025-11-25

Pages: 145 Pages

Report ld: 5114309

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Cosmetic Grade Nicotinamide Mononucleotide Market Size(US$)

CAGR 2025-2031

15.2%

Market Size,2031

USD 27.72

Million

Market Snapshot

Market Size in 2025 (Value)

US$ 11.88 million

Market Forecast in 2031(Value)

US$ 27.72 million

CAGR

15.2%

Years Considered

2020-2031

Base Year

2025

Forecast Period

2025-2031

Source: Secondary research, interviews with experts, and QYResearch analysis

The global Cosmetic Grade Nicotinamide Mononucleotide market is projected to grow from US$ 10.72 million in 2024 to US$ 27.72 million by 2031, at a CAGR of 15.2% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.

Cosmetic grade nicotinamide mononucleotide (NMN) is a niche but fast-growing part of both the NMN and cosmetic ingredients markets. In simple terms, NMN is a derivative of vitamin B3 and a direct precursor to NAD⁺, a molecule that cells use for energy, DNA repair, and many basic functions. When we talk about “cosmetic grade” NMN, we mean NMN that is produced and tested specifically for use on the skin, not for eating. Suppliers label it as “cosmetic grade, not food grade”, and sell it as a high-purity (usually ≥99%) active ingredient for use in creams, serums, masks and other skincare products.

From a market definition point of view, cosmetic grade NMN sits in the overlap of three areas: advanced cosmetic actives, NAD⁺-boosting “longevity” ingredients, and next-generation vitamin B3-type products. Many websites that sell cosmetic raw materials describe NMN as an “anti-aging superhero” ingredient that offers similar benefits to niacinamide (another B3 form) but with a stronger effect, such as helping moisturize the skin, strengthen the barrier, reduce wrinkles, brighten tone and improve hyperpigmentation. These claims are based on NMN’s biological role as a NAD⁺ precursor and on early research showing positive effects on skin cells and animal models, which has encouraged formulators to position NMN as a premium, science-based cosmetic active.

In 2024, global Cosmetic Grade Nicotinamide Mononucleotide production reached approximately 4.3 MT, with an average global market price of around US$ 2,479 per kg. The global single-line production capacity ranges from 0.5 to 1 MT per year. The industry's gross profit margin is approximately 30%-50%.

Market trends for cosmetic grade NMN are closely tied to the larger “longevity” and “science-based skincare” movements. Over the last few years, NAD⁺, NMN and related molecules have become popular in the wellness and longevity community, with large investments and heated scientific debates about how well these strategies actually work in humans. At the same time, beauty brands have been racing to add more “clinical” and “lab-tested” stories to their products. NAD⁺ skincare, which focuses on ingredients that maintain or raise NAD⁺ levels in skin cells, has begun to appear in fashion and lifestyle media as a new type of anti-aging approach. Cosmetic grade NMN fits directly into this trend, allowing brands to market themselves as sitting at the intersection of dermatology, anti-aging research and premium cosmetics.

Another strong driver is the need for differentiation in a very crowded anti-aging skincare market. Niacinamide, retinoids, vitamin C and peptides are now widely used and understood by consumers, which makes it harder for brands to stand out by using these ingredients alone. NMN, as a “next-generation B3” and NAD⁺ precursor, offers a fresh story. Suppliers highlight that NMN can offer all the typical niacinamide benefits (improving moisture, barrier function, tone and fine lines) with a “higher intensity” and extra support for cellular energy and repair. Because it is still relatively new, NMN gives brands the chance to launch hero products with unique messaging, higher price points, and a sense of cutting-edge innovation.

The rise of premium and dermocosmetic segments is also shaping this market. Many new NMN skincare launches position themselves as “clinical-grade,” “doctor-backed,” or “med-spa” style products, often combining NMN with other powerful actives such as peptides, hyaluronic acid, growth factors and retinoids. Cosmetic grade NMN is attractive in this context because it comes with high purity, clear documentation, and a technical data package that fits the expectations of dermatologists, aestheticians and advanced skincare consumers. Dermatology-style brands are also interested in NMN’s reported anti-inflammatory and barrier-supporting actions, which may be useful for sensitive, damaged or post-procedure skin.

Report Includes:

This definitive report equips business leaders, decision-makers and stakeholders with a 360° view of the global Cosmetic Grade Nicotinamide Mononucleotide market, seamlessly integrating production capacity and sales performance across the value chain. It analyzes historical production, revenue, and sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.

By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.

Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.

Critical competitive intelligence profiles manufacturers—capacity, sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.

A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.

MARKET SEGMENTATION

By Company

GeneHarbor
Herbalmax
Genex Formulas
EffePharm
Mirailab Bioscience
Bontac-bio
ABA Chemical
CELFULL

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Concentration≥98%
Concentration＜98%

Segment by Application

Skin Care Products
Facial Care Products
Hair Care Products

Segment by Category

Enzymatic Synthesis
Chemical Synthesis

Segment by Division

Direct-to-consumer Online
Offline Retail
Professional Channel

biaoTi CHAPTER OUTLINE

Chapter 1: Defines the Cosmetic Grade Nicotinamide Mononucleotide study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.

Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts

Chapter 3: Maps global production capacity, utilization, and market share (2020–2031), identifies efficient hubs, reveals regulatory/trade policy impacts and bottlenecks.

Chapter 4: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.

Chapter 5: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks

Chapter 6: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.

Chapter 7: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.

Chapter 8: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.

Chapter 9: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.

Chapter 10: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.

Chapter 11: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles

Chapter 12: Profiles manufacturers in depth—details product specs, capacity, sales, revenue, margins; top manufactures 2024 sales breakdowns by product type, by Application, by sales region SWOT analysis, and recent strategic developments.

Chapter 13: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint and technology, cost drivers, plus downstream channels and distributor roles.

Chapter 14: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.

Chapter 15: Actionable conclusions and strategic recommendations.

WHY THIS REPORT

Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:

Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:

Allocate capital strategically to high growth regions (Chapters 7–11) and margin rich segments (Chapter 5).

Negotiate from strength with suppliers (Chapter 13) and customers (Chapter 6) using cost and demand intelligence.

Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 4 and 12).

Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 13 and 14).

Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Study Coverage

1.1 Introduction to Cosmetic Grade Nicotinamide Mononucleotide: Definition, Properties, and Key Attributes

1.2 Market Segmentation by Type

1.2.1 Global Cosmetic Grade Nicotinamide Mononucleotide Market Size by Type, 2020 VS 2024 VS 2031

1.2.2 Concentration≥98%

1.2.3 Concentration＜98%

1.3 Market Segmentation by Application

1.3.1 Global Cosmetic Grade Nicotinamide Mononucleotide Market Size by Application, 2020 VS 2024 VS 2031

1.3.2 Skin Care Products

1.3.3 Facial Care Products

1.3.4 Hair Care Products

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Executive Summary

2.1 Global Cosmetic Grade Nicotinamide Mononucleotide Revenue Estimates and Forecasts 2020-2031

2.2 Global Cosmetic Grade Nicotinamide Mononucleotide Revenue by Region

2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031

2.2.2 Historical and Forecasted Revenue by Region (2020--2031)

2.2.3 Global Revenue Market Share by Region (2020-2031)

2.3 Global Cosmetic Grade Nicotinamide Mononucleotide Sales Estimates and Forecasts 2020-2031

2.4 Global Cosmetic Grade Nicotinamide Mononucleotide Sales by Region

2.4.1 Sales Comparison: 2020 VS 2024 VS 2031

2.4.2 Historical and Forecasted Sales by Region (2020-2031)

2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends

2.4.4 Global Sales Market Share by Region (2020-2031)

3 Global Production Analysis

3.1 Global Cosmetic Grade Nicotinamide Mononucleotide Production Capacity and Utilization Rates (2020–2031)

3.2 Regional Production: Comparative Analysis (2020 VS 2024 VS 2031)

3.3 Regional Production Dynamics

3.3.1 Historic Production by Region (2020-2025)

3.3.2 Forecasted Production by Region (2026-2031)

3.3.3 Production Market Share by Region (2020-2031)

3.3.4 Regulatory and Trade Policy Impact on Production

3.3.5 Production Capacity Enablers and Constraints

3.4 Key Regional Production Hubs

3.4.1 North America

3.4.2 Europe

3.4.3 China

3.4.4 Japan

4 Competition by Manufacturers

4.1 Global Cosmetic Grade Nicotinamide Mononucleotide Sales by Manufacturers

4.1.1 Global Sales Volume by Manufacturers (2020-2025)

4.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)

4.2 Global Cosmetic Grade Nicotinamide Mononucleotide Manufacturer Revenue Rankings and Tiers

4.2.1 Global Revenue (Value) by Manufacturers (2020-2025)

4.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)

4.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)

4.3 Manufacturer Profitability Profiles and Pricing Strategies

4.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)

4.3.2 Manufacturer-Level Price Trends (2020-2025)

4.4 Key Manufacturers Manufacturing Base and Headquarters

4.5 Main Product Type Market Size by Manufacturers

4.5.1 Concentration≥98% Market Size by Manufacturers

4.5.2 Concentration＜98% Market Size by Manufacturers

4.6 Global Cosmetic Grade Nicotinamide Mononucleotide Market Concentration and Dynamics

4.6.1 Global Market Concentration (CR5 and HHI)

4.6.2 Entrant/Exit Impact Analysis

4.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment

5 Global Product Segmentation Analysis

5.1 Global Cosmetic Grade Nicotinamide Mononucleotide Sales Performance by Type

5.1.1 Global Historical and Forecasted Sales by Type (2020-2031)

5.1.2 Global Sales Market Share by Type (2020-2031)

5.2 Global Cosmetic Grade Nicotinamide Mononucleotide Revenue Trends by Type

5.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)

5.2.2 Global Revenue Market Share by Type (2020-2031)

5.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)

5.4 Product Technology Differentiation

5.5 Subtype Dynamics: Growth Leaders, Profitability and Risk

5.5.1 High-Growth Niches and Adoption Drivers

5.5.2 Profitability Hotspots and Cost Drivers

5.5.3 Substitution Threats

6 Global Downstream Application Analysis

6.1 Global Cosmetic Grade Nicotinamide Mononucleotide Sales by Application

6.1.1 Global Historical and Forecasted Sales by Application (2020-2031)

6.1.2 Global Sales Market Share by Application (2020-2031)

6.1.3 High-Growth Application Identification

6.1.4 Emerging Application Case Studies

6.2 Global Cosmetic Grade Nicotinamide Mononucleotide Revenue by Application

6.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)

6.2.2 Revenue Market Share by Application (2020-2031)

6.3 Global Pricing Dynamics by Application (2020-2031)

6.4 Downstream Customer Analysis

6.4.1 Top Customers by Region

6.4.2 Top Customers by Application

7 North America

7.1 North America Sales Volume and Revenue (2020-2031)

7.2 North America Key Manufacturers Sales Revenue in 2024

7.3 North America Cosmetic Grade Nicotinamide Mononucleotide Sales and Revenue by Type (2020-2031)

7.4 North America Cosmetic Grade Nicotinamide Mononucleotide Sales and Revenue by Application (2020-2031)

7.5 North America Growth Accelerators and Market Barriers

7.6 North America Cosmetic Grade Nicotinamide Mononucleotide Market Size by Country

7.6.1 North America Revenue by Country

7.6.2 North America Sales Trends by Country

7.6.3 US

7.6.4 Canada

7.6.5 Mexico

8 Europe

8.1 Europe Sales Volume and Revenue (2020-2031)

8.2 Europe Key Manufacturers Sales Revenue in 2024

8.3 Europe Cosmetic Grade Nicotinamide Mononucleotide Sales and Revenue by Type (2020-2031)

8.4 Europe Cosmetic Grade Nicotinamide Mononucleotide Sales and Revenue by Application (2020-2031)

8.5 Europe Growth Accelerators and Market Barriers

8.6 Europe Cosmetic Grade Nicotinamide Mononucleotide Market Size by Country

8.6.1 Europe Revenue by Country

8.6.2 Europe Sales Trends by Country

8.6.3 Germany

8.6.4 France

8.6.5 U.K.

8.6.6 Italy

8.6.7 Russia

9 Asia-Pacific

9.1 Asia-Pacific Sales Volume and Revenue (2020-2031)

9.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024

9.3 Asia-Pacific Cosmetic Grade Nicotinamide Mononucleotide Sales and Revenue by Type (2020-2031)

9.4 Asia-Pacific Cosmetic Grade Nicotinamide Mononucleotide Sales and Revenue by Application (2020-2031)

9.5 Asia-Pacific Cosmetic Grade Nicotinamide Mononucleotide Market Size by Region

9.5.1 Asia-Pacific Revenue by Region

9.5.2 Asia-Pacific Sales Trends by Region

9.6 Asia-Pacific Growth Accelerators and Market Barriers

9.7 Southeast Asia

9.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)

9.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand

9.8 China

9.9 Japan

9.10 South Korea

9.11 China Taiwan

9.12 India

10 Central and South America

10.1 Central and South America Sales Volume and Revenue (2020-2031)

10.2 Central and South America Key Manufacturers Sales Revenue in 2024

10.3 Central and South America Cosmetic Grade Nicotinamide Mononucleotide Sales and Revenue by Type (2020-2031)

10.4 Central and South America Cosmetic Grade Nicotinamide Mononucleotide Sales and Revenue by Application (2020-2031)

10.5 Central and South America Investment Opportunities and Key Challenges

10.6 Central and South America Cosmetic Grade Nicotinamide Mononucleotide Market Size by Country

10.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)

10.6.2 Brazil

10.6.3 Argentina

11 Middle East and Africa

11.1 Middle East and Africa Sales Volume and Revenue (2020-2031)

11.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024

11.3 Middle East and Africa Cosmetic Grade Nicotinamide Mononucleotide Sales and Revenue by Type (2020-2031)

11.4 Middle East and Africa Cosmetic Grade Nicotinamide Mononucleotide Sales and Revenue by Application (2020-2031)

11.5 Middle East and Africa Investment Opportunities and Key Challenges

11.6 Middle East and Africa Cosmetic Grade Nicotinamide Mononucleotide Market Size by Country

11.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)

11.6.2 GCC Countries

11.6.3 Turkey

11.6.4 Egypt

11.6.5 South Africa

12 Corporate Profile

12.1 GeneHarbor

12.1.1 GeneHarbor Corporation Information

12.1.2 GeneHarbor Business Overview

12.1.3 GeneHarbor Cosmetic Grade Nicotinamide Mononucleotide Product Models, Descriptions and Specifications

12.1.4 GeneHarbor Cosmetic Grade Nicotinamide Mononucleotide Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.1.5 GeneHarbor Cosmetic Grade Nicotinamide Mononucleotide Sales by Product in 2024

12.1.6 GeneHarbor Cosmetic Grade Nicotinamide Mononucleotide Sales by Application in 2024

12.1.7 GeneHarbor Cosmetic Grade Nicotinamide Mononucleotide Sales by Geographic Area in 2024

12.1.8 GeneHarbor Cosmetic Grade Nicotinamide Mononucleotide SWOT Analysis

12.1.9 GeneHarbor Recent Developments

12.2 Herbalmax

12.2.1 Herbalmax Corporation Information

12.2.2 Herbalmax Business Overview

12.2.3 Herbalmax Cosmetic Grade Nicotinamide Mononucleotide Product Models, Descriptions and Specifications

12.2.4 Herbalmax Cosmetic Grade Nicotinamide Mononucleotide Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.2.5 Herbalmax Cosmetic Grade Nicotinamide Mononucleotide Sales by Product in 2024

12.2.6 Herbalmax Cosmetic Grade Nicotinamide Mononucleotide Sales by Application in 2024

12.2.7 Herbalmax Cosmetic Grade Nicotinamide Mononucleotide Sales by Geographic Area in 2024

12.2.8 Herbalmax Cosmetic Grade Nicotinamide Mononucleotide SWOT Analysis

12.2.9 Herbalmax Recent Developments

12.3 Genex Formulas

12.3.1 Genex Formulas Corporation Information

12.3.2 Genex Formulas Business Overview

12.3.3 Genex Formulas Cosmetic Grade Nicotinamide Mononucleotide Product Models, Descriptions and Specifications

12.3.4 Genex Formulas Cosmetic Grade Nicotinamide Mononucleotide Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.3.5 Genex Formulas Cosmetic Grade Nicotinamide Mononucleotide Sales by Product in 2024

12.3.6 Genex Formulas Cosmetic Grade Nicotinamide Mononucleotide Sales by Application in 2024

12.3.7 Genex Formulas Cosmetic Grade Nicotinamide Mononucleotide Sales by Geographic Area in 2024

12.3.8 Genex Formulas Cosmetic Grade Nicotinamide Mononucleotide SWOT Analysis

12.3.9 Genex Formulas Recent Developments

12.4 EffePharm

12.4.1 EffePharm Corporation Information

12.4.2 EffePharm Business Overview

12.4.3 EffePharm Cosmetic Grade Nicotinamide Mononucleotide Product Models, Descriptions and Specifications

12.4.4 EffePharm Cosmetic Grade Nicotinamide Mononucleotide Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.4.5 EffePharm Cosmetic Grade Nicotinamide Mononucleotide Sales by Product in 2024

12.4.6 EffePharm Cosmetic Grade Nicotinamide Mononucleotide Sales by Application in 2024

12.4.7 EffePharm Cosmetic Grade Nicotinamide Mononucleotide Sales by Geographic Area in 2024

12.4.8 EffePharm Cosmetic Grade Nicotinamide Mononucleotide SWOT Analysis

12.4.9 EffePharm Recent Developments

12.5 Mirailab Bioscience

12.5.1 Mirailab Bioscience Corporation Information

12.5.2 Mirailab Bioscience Business Overview

12.5.3 Mirailab Bioscience Cosmetic Grade Nicotinamide Mononucleotide Product Models, Descriptions and Specifications

12.5.4 Mirailab Bioscience Cosmetic Grade Nicotinamide Mononucleotide Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.5.5 Mirailab Bioscience Cosmetic Grade Nicotinamide Mononucleotide Sales by Product in 2024

12.5.6 Mirailab Bioscience Cosmetic Grade Nicotinamide Mononucleotide Sales by Application in 2024

12.5.7 Mirailab Bioscience Cosmetic Grade Nicotinamide Mononucleotide Sales by Geographic Area in 2024

12.5.8 Mirailab Bioscience Cosmetic Grade Nicotinamide Mononucleotide SWOT Analysis

12.5.9 Mirailab Bioscience Recent Developments

12.6 Bontac-bio

12.6.1 Bontac-bio Corporation Information

12.6.2 Bontac-bio Business Overview

12.6.3 Bontac-bio Cosmetic Grade Nicotinamide Mononucleotide Product Models, Descriptions and Specifications

12.6.4 Bontac-bio Cosmetic Grade Nicotinamide Mononucleotide Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.6.5 Bontac-bio Recent Developments

12.7 ABA Chemical

12.7.1 ABA Chemical Corporation Information

12.7.2 ABA Chemical Business Overview

12.7.3 ABA Chemical Cosmetic Grade Nicotinamide Mononucleotide Product Models, Descriptions and Specifications

12.7.4 ABA Chemical Cosmetic Grade Nicotinamide Mononucleotide Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.7.5 ABA Chemical Recent Developments

12.8 CELFULL

12.8.1 CELFULL Corporation Information

12.8.2 CELFULL Business Overview

12.8.3 CELFULL Cosmetic Grade Nicotinamide Mononucleotide Product Models, Descriptions and Specifications

12.8.4 CELFULL Cosmetic Grade Nicotinamide Mononucleotide Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.8.5 CELFULL Recent Developments

13 Value Chain and Supply-Chain Analysis

13.1 Cosmetic Grade Nicotinamide Mononucleotide Industry Chain

13.2 Cosmetic Grade Nicotinamide Mononucleotide Upstream Materials Analysis

13.2.1 Raw Materials

13.2.2 Key Suppliers Market Share & Risk Assessment

13.3 Cosmetic Grade Nicotinamide Mononucleotide Integrated Production Analysis

13.3.1 Manufacturing Footprint Analysis

13.3.2 Production Technology Overview

13.3.3 Regional Cost Drivers

13.4 Cosmetic Grade Nicotinamide Mononucleotide Sales Channels and Distribution Networks

13.4.1 Sales Channels

13.4.2 Distributors

14 Cosmetic Grade Nicotinamide Mononucleotide Market Dynamics

14.1 Industry Trends and Evolution

14.2 Market Growth Drivers and Emerging Opportunities

14.3 Market Challenges, Risks, and Restraints

15 Key Findings in the Global Cosmetic Grade Nicotinamide Mononucleotide Study

16 Appendix

16.1 Research Methodology

16.1.1 Methodology/Research Approach

16.1.1.1 Research Programs/Design

16.1.1.2 Market Size Estimation

16.1.1.3 Market Breakdown and Data Triangulation

16.1.2 Data Source

16.1.2.1 Secondary Sources

16.1.2.2 Primary Sources

16.2 Author Details

TABLE OF FIGURES

List of Tables

Table 1. Global Cosmetic Grade Nicotinamide Mononucleotide Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Table 2. Global Cosmetic Grade Nicotinamide Mononucleotide Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)

Table 3. Global Cosmetic Grade Nicotinamide Mononucleotide Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 4. Global Cosmetic Grade Nicotinamide Mononucleotide Revenue by Region (2020-2025) & (US$ Million)

Table 5. Global Cosmetic Grade Nicotinamide Mononucleotide Revenue by Region (2026-2031) & (US$ Million)

Table 6. Global Cosmetic Grade Nicotinamide Mononucleotide Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Tons)

Table 7. Global Cosmetic Grade Nicotinamide Mononucleotide Sales by Region (2020-2025) & (Tons)

Table 8. Global Cosmetic Grade Nicotinamide Mononucleotide Sales by Region (2026-2031) & (Tons)

Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 10. Global Cosmetic Grade Nicotinamide Mononucleotide Production Growth Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Tons)

Table 11. Global Cosmetic Grade Nicotinamide Mononucleotide Production by Region (2020-2025) & (Tons)

Table 12. Global Cosmetic Grade Nicotinamide Mononucleotide Production by Region (2026-2031) & (Tons)

Table 13. Global Cosmetic Grade Nicotinamide Mononucleotide Sales by Manufacturers (2020-2025) & (Tons)

Table 14. Global Cosmetic Grade Nicotinamide Mononucleotide Sales Share by Manufacturers (2020-2025)

Table 15. Global Cosmetic Grade Nicotinamide Mononucleotide Revenue by Manufacturers (2020-2025) & (US$ Million)

Table 16. Global Cosmetic Grade Nicotinamide Mononucleotide Revenue Market Share by Manufacturers (2020-2025)

Table 17. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)

Table 18. Global Cosmetic Grade Nicotinamide Mononucleotide by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cosmetic Grade Nicotinamide Mononucleotide as of 2024)

Table 19. Global Cosmetic Grade Nicotinamide Mononucleotide Average Gross Margin (%) by Manufacturer (2020 VS 2024)

Table 20. Global Cosmetic Grade Nicotinamide Mononucleotide Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Kg)

Table 21. Key Manufacturers Cosmetic Grade Nicotinamide Mononucleotide Manufacturing Base and Headquarters

Table 22. Global Cosmetic Grade Nicotinamide Mononucleotide Market Concentration Ratio (CR5 and HHI)

Table 23. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis

Table 24. Key Mergers & Acquisitions, Expansion Plans, R&D Investment

Table 25. Global Cosmetic Grade Nicotinamide Mononucleotide Sales by Type (2020-2025) & (Tons)

Table 26. Global Cosmetic Grade Nicotinamide Mononucleotide Sales by Type (2026-2031) & (Tons)

Table 27. Global Cosmetic Grade Nicotinamide Mononucleotide Revenue by Type (2020-2025) & (US$ Million)

Table 28. Global Cosmetic Grade Nicotinamide Mononucleotide Revenue by Type (2026-2031) & (US$ Million)

Table 29. Global Cosmetic Grade Nicotinamide Mononucleotide ASP by Type (2020-2031) & (US$/Kg)

Table 30. Technical Specifications by Key Product Type

Table 31. Global Cosmetic Grade Nicotinamide Mononucleotide Sales by Application (2020-2025) & (Tons)

Table 32. Global Cosmetic Grade Nicotinamide Mononucleotide Sales by Application (2026-2031) & (Tons)

Table 33. Cosmetic Grade Nicotinamide Mononucleotide High-Growth Sectors Demand CAGR (2024-2031)

Table 34. Global Cosmetic Grade Nicotinamide Mononucleotide Revenue by Application (2020-2025) & (US$ Million)

Table 35. Global Cosmetic Grade Nicotinamide Mononucleotide Revenue by Application (2026-2031) & (US$ Million)

Table 36. Global Cosmetic Grade Nicotinamide Mononucleotide ASP by Application (2020-2031) & (US$/Kg)

Table 37. Top Customers by Region

Table 38. Top Customers by Application

Table 39. North America Cosmetic Grade Nicotinamide Mononucleotide Growth Accelerators and Market Barriers

Table 40. North America Cosmetic Grade Nicotinamide Mononucleotide Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 41. North America Cosmetic Grade Nicotinamide Mononucleotide Sales (Tons) by Country (2020 VS 2024 VS 2031)

Table 42. Europe Cosmetic Grade Nicotinamide Mononucleotide Growth Accelerators and Market Barriers

Table 43. Europe Cosmetic Grade Nicotinamide Mononucleotide Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 44. Europe Cosmetic Grade Nicotinamide Mononucleotide Sales (Tons) by Country (2020 VS 2024 VS 2031)

Table 45. Asia-Pacific Cosmetic Grade Nicotinamide Mononucleotide Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Asia-Pacific Cosmetic Grade Nicotinamide Mononucleotide Sales (Tons) by Country (2020 VS 2024 VS 2031)

Table 47. Asia-Pacific Cosmetic Grade Nicotinamide Mononucleotide Growth Accelerators and Market Barriers

Table 48. Southeast Asia Cosmetic Grade Nicotinamide Mononucleotide Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 49. Central and South America Cosmetic Grade Nicotinamide Mononucleotide Investment Opportunities and Key Challenges

Table 50. Central and South America Cosmetic Grade Nicotinamide Mononucleotide Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 51. Middle East and Africa Cosmetic Grade Nicotinamide Mononucleotide Investment Opportunities and Key Challenges

Table 52. Middle East and Africa Cosmetic Grade Nicotinamide Mononucleotide Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 53. GeneHarbor Corporation Information

Table 54. GeneHarbor Description and Major Businesses

Table 55. GeneHarbor Product Models, Descriptions and Specifications

Table 56. GeneHarbor Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 57. GeneHarbor Sales Value Proportion by Product in 2024

Table 58. GeneHarbor Sales Value Proportion by Application in 2024

Table 59. GeneHarbor Sales Value Proportion by Geographic Area in 2024

Table 60. GeneHarbor Cosmetic Grade Nicotinamide Mononucleotide SWOT Analysis

Table 61. GeneHarbor Recent Developments

Table 62. Herbalmax Corporation Information

Table 63. Herbalmax Description and Major Businesses

Table 64. Herbalmax Product Models, Descriptions and Specifications

Table 65. Herbalmax Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 66. Herbalmax Sales Value Proportion by Product in 2024

Table 67. Herbalmax Sales Value Proportion by Application in 2024

Table 68. Herbalmax Sales Value Proportion by Geographic Area in 2024

Table 69. Herbalmax Cosmetic Grade Nicotinamide Mononucleotide SWOT Analysis

Table 70. Herbalmax Recent Developments

Table 71. Genex Formulas Corporation Information

Table 72. Genex Formulas Description and Major Businesses

Table 73. Genex Formulas Product Models, Descriptions and Specifications

Table 74. Genex Formulas Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 75. Genex Formulas Sales Value Proportion by Product in 2024

Table 76. Genex Formulas Sales Value Proportion by Application in 2024

Table 77. Genex Formulas Sales Value Proportion by Geographic Area in 2024

Table 78. Genex Formulas Cosmetic Grade Nicotinamide Mononucleotide SWOT Analysis

Table 79. Genex Formulas Recent Developments

Table 80. EffePharm Corporation Information

Table 81. EffePharm Description and Major Businesses

Table 82. EffePharm Product Models, Descriptions and Specifications

Table 83. EffePharm Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 84. EffePharm Sales Value Proportion by Product in 2024

Table 85. EffePharm Sales Value Proportion by Application in 2024

Table 86. EffePharm Sales Value Proportion by Geographic Area in 2024

Table 87. EffePharm Cosmetic Grade Nicotinamide Mononucleotide SWOT Analysis

Table 88. EffePharm Recent Developments

Table 89. Mirailab Bioscience Corporation Information

Table 90. Mirailab Bioscience Description and Major Businesses

Table 91. Mirailab Bioscience Product Models, Descriptions and Specifications

Table 92. Mirailab Bioscience Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 93. Mirailab Bioscience Sales Value Proportion by Product in 2024

Table 94. Mirailab Bioscience Sales Value Proportion by Application in 2024

Table 95. Mirailab Bioscience Sales Value Proportion by Geographic Area in 2024

Table 96. Mirailab Bioscience Cosmetic Grade Nicotinamide Mononucleotide SWOT Analysis

Table 97. Mirailab Bioscience Recent Developments

Table 98. Bontac-bio Corporation Information

Table 99. Bontac-bio Description and Major Businesses

Table 100. Bontac-bio Product Models, Descriptions and Specifications

Table 101. Bontac-bio Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 102. Bontac-bio Recent Developments

Table 103. ABA Chemical Corporation Information

Table 104. ABA Chemical Description and Major Businesses

Table 105. ABA Chemical Product Models, Descriptions and Specifications

Table 106. ABA Chemical Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 107. ABA Chemical Recent Developments

Table 108. CELFULL Corporation Information

Table 109. CELFULL Description and Major Businesses

Table 110. CELFULL Product Models, Descriptions and Specifications

Table 111. CELFULL Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 112. CELFULL Recent Developments

Table 113. Key Raw Materials Distribution

Table 114. Raw Materials Key Suppliers

Table 115. Critical Raw Material Supplier Concentration (2024) & Risk Index

Table 116. Milestones in Production Technology Evolution

Table 117. Distributors List

Table 118. Market Trends and Market Evolution

Table 119. Market Drivers and Opportunities

Table 120. Market Challenges, Risks, and Restraints

Table 121. Research Programs/Design for This Report

Table 122. Key Data Information from Secondary Sources

Table 123. Key Data Information from Primary Sources

List of Figures

Figure 1. Cosmetic Grade Nicotinamide Mononucleotide Product Picture

Figure 2. Global Cosmetic Grade Nicotinamide Mononucleotide Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Figure 3. Concentration≥98% Product Picture

Figure 4. Concentration＜98% Product Picture

Figure 5. Global Cosmetic Grade Nicotinamide Mononucleotide Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)

Figure 6. Skin Care Products

Figure 7. Facial Care Products

Figure 8. Hair Care Products

Figure 9. Cosmetic Grade Nicotinamide Mononucleotide Report Years Considered

Figure 10. Global Cosmetic Grade Nicotinamide Mononucleotide Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 11. Global Cosmetic Grade Nicotinamide Mononucleotide Revenue (2020-2031) & (US$ Million)

Figure 12. Global Cosmetic Grade Nicotinamide Mononucleotide Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Figure 13. Global Cosmetic Grade Nicotinamide Mononucleotide Revenue Market Share by Region (2020-2031)

Figure 14. Global Cosmetic Grade Nicotinamide Mononucleotide Sales (2020-2031) & (Tons)

Figure 15. Global Cosmetic Grade Nicotinamide Mononucleotide Sales (CAGR) by Region (2020-2031) (Tons)

Figure 16. Global Cosmetic Grade Nicotinamide Mononucleotide Sales Market Share by Region (2020-2031)

Figure 17. Global Cosmetic Grade Nicotinamide Mononucleotide Capacity, Production and Utilization (2020-2031) & (Tons)

Figure 18. Global Cosmetic Grade Nicotinamide Mononucleotide Production Trend by Region (2020-2031) (Tons)

Figure 19. Global Cosmetic Grade Nicotinamide Mononucleotide Production Market Share by Region (2020-2031)

Figure 20. Production Capacity Enablers & Constraints

Figure 21. Cosmetic Grade Nicotinamide Mononucleotide Production Growth Rate in North America (2020-2031) & (Tons)

Figure 22. Cosmetic Grade Nicotinamide Mononucleotide Production Growth Rate in Europe (2020-2031) & (Tons)

Figure 23. Cosmetic Grade Nicotinamide Mononucleotide Production Growth Rate in China (2020-2031) & (Tons)

Figure 24. Cosmetic Grade Nicotinamide Mononucleotide Production Growth Rate in Japan (2020-2031) & (Tons)

Figure 25. Top 5 and Top 10 Manufacturers Cosmetic Grade Nicotinamide Mononucleotide Sales Volume Market Share in 2024

Figure 26. Global Cosmetic Grade Nicotinamide Mononucleotide Revenue Market Share Ranking (2024)

Figure 27. Tier Distribution by Revenue Contribution (2020 VS 2024)

Figure 28. Concentration≥98% Revenue Market Share by Manufacturer in 2024

Figure 29. Concentration＜98% Revenue Market Share by Manufacturer in 2024

Figure 30. Type Eight Revenue Market Share by Manufacturer in 2024

Figure 31. Type Nine Revenue Market Share by Manufacturer in 2024

Figure 32. Global Cosmetic Grade Nicotinamide Mononucleotide Sales Market Share by Type (2020-2031)

Figure 33. Global Cosmetic Grade Nicotinamide Mononucleotide Revenue Market Share by Type (2020-2031)

Figure 34. Global Cosmetic Grade Nicotinamide Mononucleotide Sales Market Share by Application (2020-2031)

Figure 35. Global Cosmetic Grade Nicotinamide Mononucleotide Revenue Market Share by Application (2020-2031)

Figure 36. North America Cosmetic Grade Nicotinamide Mononucleotide Sales YoY (2020-2031) & (Tons)

Figure 37. North America Cosmetic Grade Nicotinamide Mononucleotide Revenue YoY (2020-2031) & (US$ Million)

Figure 38. North America Top 5 Manufacturers Cosmetic Grade Nicotinamide Mononucleotide Sales Revenue (US$ Million) in 2024

Figure 39. North America Cosmetic Grade Nicotinamide Mononucleotide Sales Volume (Tons) by Type (2020- 2031)

Figure 40. North America Cosmetic Grade Nicotinamide Mononucleotide Sales Revenue (US$ Million) by Type (2020 - 2031)

Figure 41. North America Cosmetic Grade Nicotinamide Mononucleotide Sales Volume (Tons) by Application (2020-2031)

Figure 42. North America Cosmetic Grade Nicotinamide Mononucleotide Sales Revenue (US$ Million) by Application (2020-2031)

Figure 43. US Cosmetic Grade Nicotinamide Mononucleotide Revenue (2020-2031) & (US$ Million)

Figure 44. Canada Cosmetic Grade Nicotinamide Mononucleotide Revenue (2020-2031) & (US$ Million)

Figure 45. Mexico Cosmetic Grade Nicotinamide Mononucleotide Revenue (2020-2031) & (US$ Million)

Figure 46. Europe Cosmetic Grade Nicotinamide Mononucleotide Sales YoY (2020-2031) & (Tons)

Figure 47. Europe Cosmetic Grade Nicotinamide Mononucleotide Revenue YoY (2020-2031) & (US$ Million)

Figure 48. Europe Top 5 Manufacturers Cosmetic Grade Nicotinamide Mononucleotide Sales Revenue (US$ Million) in 2024

Figure 49. Europe Cosmetic Grade Nicotinamide Mononucleotide Sales Volume (Tons) by Type (2020-2031)

Figure 50. Europe Cosmetic Grade Nicotinamide Mononucleotide Sales Revenue (US$ Million) by Type (2020-2031)

Figure 51. Europe Cosmetic Grade Nicotinamide Mononucleotide Sales Volume (Tons) by Application (2020-2031)

Figure 52. Europe Cosmetic Grade Nicotinamide Mononucleotide Sales Revenue (US$ Million) by Application (2020-2031)

Figure 53. Germany Cosmetic Grade Nicotinamide Mononucleotide Revenue (2020-2031) & (US$ Million)

Figure 54. France Cosmetic Grade Nicotinamide Mononucleotide Revenue (2020-2031) & (US$ Million)

Figure 55. U.K. Cosmetic Grade Nicotinamide Mononucleotide Revenue (2020-2031) & (US$ Million)

Figure 56. Italy Cosmetic Grade Nicotinamide Mononucleotide Revenue (2020-2031) & (US$ Million)

Figure 57. Russia Cosmetic Grade Nicotinamide Mononucleotide Revenue (2020-2031) & (US$ Million)

Figure 58. Asia-Pacific Cosmetic Grade Nicotinamide Mononucleotide Sales YoY (2020-2031) & (Tons)

Figure 59. Asia-Pacific Cosmetic Grade Nicotinamide Mononucleotide Revenue YoY (2020-2031) & (US$ Million)

Figure 60. Asia-Pacific Top 8 Manufacturers Cosmetic Grade Nicotinamide Mononucleotide Sales Revenue (US$ Million) in 2024

Figure 61. Asia-Pacific Cosmetic Grade Nicotinamide Mononucleotide Sales Volume (Tons) by Type (2020- 2031)

Figure 62. Asia-Pacific Cosmetic Grade Nicotinamide Mononucleotide Sales Revenue (US$ Million) by Type (2020- 2031)

Figure 63. Asia-Pacific Cosmetic Grade Nicotinamide Mononucleotide Sales Volume (Tons) by Application (2020-2031)

Figure 64. Asia-Pacific Cosmetic Grade Nicotinamide Mononucleotide Sales Revenue (US$ Million) by Application (2020-2031)

Figure 65. Indonesia Cosmetic Grade Nicotinamide Mononucleotide Revenue (2020-2031) & (US$ Million)

Figure 66. Japan Cosmetic Grade Nicotinamide Mononucleotide Revenue (2020-2031) & (US$ Million)

Figure 67. South Korea Cosmetic Grade Nicotinamide Mononucleotide Revenue (2020-2031) & (US$ Million)

Figure 68. China Taiwan Cosmetic Grade Nicotinamide Mononucleotide Revenue (2020-2031) & (US$ Million)

Figure 69. India Cosmetic Grade Nicotinamide Mononucleotide Revenue (2020-2031) & (US$ Million)

Figure 70. Central and South America Cosmetic Grade Nicotinamide Mononucleotide Sales YoY (2020-2031) & (Tons)

Figure 71. Central and South America Cosmetic Grade Nicotinamide Mononucleotide Revenue YoY (2020-2031) & (US$ Million)

Figure 72. Central and South America Top 5 Manufacturers Cosmetic Grade Nicotinamide Mononucleotide Sales Revenue (US$ Million) in 2024

Figure 73. Central and South America Cosmetic Grade Nicotinamide Mononucleotide Sales Volume (Tons) by Type (2021-2031)

Figure 74. Central and South America Cosmetic Grade Nicotinamide Mononucleotide Sales Revenue (US$ Million) by Type (2020-2031)

Figure 75. Central and South America Cosmetic Grade Nicotinamide Mononucleotide Sales Volume (Tons) by Application (2020-2031)

Figure 76. Central and South America Cosmetic Grade Nicotinamide Mononucleotide Sales Revenue (US$ Million) by Application (2020-2031)

Figure 77. Brazil Cosmetic Grade Nicotinamide Mononucleotide Revenue (2020-2025) & (US$ Million)

Figure 78. Argentina Cosmetic Grade Nicotinamide Mononucleotide Revenue (2020-2025) & (US$ Million)

Figure 79. Middle East, and Africa Cosmetic Grade Nicotinamide Mononucleotide Sales YoY (2020-2031) & (Tons)

Figure 80. Middle East and Africa Cosmetic Grade Nicotinamide Mononucleotide Revenue YoY (2020-2031) & (US$ Million)

Figure 81. Middle East and Africa Top 5 Manufacturers Cosmetic Grade Nicotinamide Mononucleotide Sales Revenue (US$ Million) in 2024

Figure 82. Middle East and Africa Cosmetic Grade Nicotinamide Mononucleotide Sales Volume (Tons) by Type (2021-2031)

Figure 83. South America Cosmetic Grade Nicotinamide Mononucleotide Sales Revenue (US$ Million) by Type (2020-2031)

Figure 84. Middle East and Africa Cosmetic Grade Nicotinamide Mononucleotide Sales Volume (Tons) by Application (2020-2031)

Figure 85. Middle East and Africa Cosmetic Grade Nicotinamide Mononucleotide Sales Revenue (US$ Million) by Application (2020-2031)

Figure 86. GCC Countries Cosmetic Grade Nicotinamide Mononucleotide Revenue (2020-2025) & (US$ Million)

Figure 87. Turkey Cosmetic Grade Nicotinamide Mononucleotide Revenue (2020-2025) & (US$ Million)

Figure 88. Egypt Cosmetic Grade Nicotinamide Mononucleotide Revenue (2020-2025) & (US$ Million)

Figure 89. South Africa Cosmetic Grade Nicotinamide Mononucleotide Revenue (2020-2025) & (US$ Million)

Figure 90. Cosmetic Grade Nicotinamide Mononucleotide Industry Chain Mapping

Figure 91. Regional Cosmetic Grade Nicotinamide Mononucleotide Manufacturing Base Distribution (%)

Figure 92. Cosmetic Grade Nicotinamide Mononucleotide Production Process

Figure 93. Regional Cosmetic Grade Nicotinamide Mononucleotide Production Cost Structure

Figure 94. Channels of Distribution (Direct Vs Distribution)

Figure 95. Bottom-up and Top-down Approaches for This Report

Figure 96. Data Triangulation

Figure 97. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Cosmetic Grade Nicotinamide Mononucleotide market? zhanKai

The top companies in the global Cosmetic Grade Nicotinamide Mononucleotide market are GeneHarbor、Herbalmax、Genex Formulas.

What was the global market size of Cosmetic Grade Nicotinamide Mononucleotide in 2025? shouQi

What was the global market size of Cosmetic Grade Nicotinamide Mononucleotide in 2031? shouQi

Which region is expected to have the highest market share? shouQi

What is the annual compound growth rate of the global Cosmetic Grade Nicotinamide Mononucleotide market size from 2025 to 2031? shouQi

Related Reports

Cosmetic Grade Nicotinamide Mononucleotide- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Cosmetic Grade Nicotinamide Mononucleotide was estimated to be worth US$ 11.88 million in 2025 and is projected to reach US$ 31.51 million, growing at a CAGR of 15.2% from 2026 to 2032.
Published Date: 2026-02-02
Pages: 105
USD 3950.00
(Single User License)
Global Cosmetic Grade Nicotinamide Mononucleotide Market Research Report 2026
The global Cosmetic Grade Nicotinamide Mononucleotide market was valued at US$ 11.88 million in 2025 and is anticipated to reach US$ 31.51 million by 2032, at a CAGR of 15.2% from 2026 to 2032.
Published Date: 2026-02-02
Pages: 133
USD 2900.00
(Single User License)
Cosmetic Grade Nicotinamide Mononucleotide - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Cosmetic Grade Nicotinamide Mononucleotide was estimated to be worth US$ 10.72 million in 2024 and is forecast to a readjusted size of US$ 27.72 million by 2031 with a CAGR of 15.2% during the forecast period 2025-2031.
Published Date: 2025-11-25
Pages: 100
USD 3950.00
(Single User License)
Global Cosmetic Grade Nicotinamide Mononucleotide Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Cosmetic Grade Nicotinamide Mononucleotide market size was US$ 10.72 million in 2024 and is forecast to a readjusted size of US$ 27.72 million by 2031 with a CAGR of 15.2% during the forecast period 2025-2031.
Published Date: 2025-11-25
Pages: 76
USD 4250.00
(Single User License)
Global Cosmetic Grade Nicotinamide Mononucleotide Market Research Report 2025
The global market for Cosmetic Grade Nicotinamide Mononucleotide was valued at US$ 10.72 million in the year 2024 and is projected to reach a revised size of US$ 27.72 million by 2031, growing at a CAGR of 15.2% during the forecast period.
Published Date: 2025-11-25
Pages: 93
USD 2900.00
(Single User License)
Cosmetic Grade Nicotinamide Mononucleotide- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Cosmetic Grade Nicotinamide Mononucleotide was estimated to be worth US$ 264 million in 2024 and is forecast to a readjusted size of US$ 307 million by 2031 with a CAGR of 2.2% during the forecast period 2025-2031.
Published Date: 2025-02-14
Pages: 102
USD 3950.00
(Single User License)
Global Cosmetic Grade Nicotinamide Mononucleotide Market Insights, Forecast to 2030
Nicotinamide mononucleotides play an important role in the energy production of human cells by participating in the intracellular synthesis of NAD (nicotinamide adenine dinucleotide, an important coenzyme in cellular energy conversion). Nicotinamide mononucleotide, which was originally present in the human body but decreases with age. Earlier experiments have shown that nicotinamide mononucleotide NMN increases NAD in the organs of laboratory rats, thus inhibiting ageing of nerves and blood vessels, and also improving the symptoms of diabetes.
Published Date: 2024-04-14
Pages: 95
USD 4900.00
(Single User License)

Cosmetic Grade Nicotinamide Mononucleotide- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Cosmetic Grade Nicotinamide Mononucleotide was estimated to be worth US$ 11.88 million in 2025 and is projected to reach US$ 31.51 million, growing at a CAGR of 15.2% from 2026 to 2032.
Published: 2026-02-02
Pages: 105
USD 3950.00 (Single User License)
Global Cosmetic Grade Nicotinamide Mononucleotide Market Research Report 2026
The global Cosmetic Grade Nicotinamide Mononucleotide market was valued at US$ 11.88 million in 2025 and is anticipated to reach US$ 31.51 million by 2032, at a CAGR of 15.2% from 2026 to 2032.
Published: 2026-02-02
Pages: 133
USD 2900.00 (Single User License)
Cosmetic Grade Nicotinamide Mononucleotide - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Cosmetic Grade Nicotinamide Mononucleotide was estimated to be worth US$ 10.72 million in 2024 and is forecast to a readjusted size of US$ 27.72 million by 2031 with a CAGR of 15.2% during the forecast period 2025-2031.
Published: 2025-11-25
Pages: 100
USD 3950.00 (Single User License)
Global Cosmetic Grade Nicotinamide Mononucleotide Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Cosmetic Grade Nicotinamide Mononucleotide market size was US$ 10.72 million in 2024 and is forecast to a readjusted size of US$ 27.72 million by 2031 with a CAGR of 15.2% during the forecast period 2025-2031.
Published: 2025-11-25
Pages: 76
USD 4250.00 (Single User License)
Global Cosmetic Grade Nicotinamide Mononucleotide Market Research Report 2025
The global market for Cosmetic Grade Nicotinamide Mononucleotide was valued at US$ 10.72 million in the year 2024 and is projected to reach a revised size of US$ 27.72 million by 2031, growing at a CAGR of 15.2% during the forecast period.
Published: 2025-11-25
Pages: 93
USD 2900.00 (Single User License)
Cosmetic Grade Nicotinamide Mononucleotide- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Cosmetic Grade Nicotinamide Mononucleotide was estimated to be worth US$ 264 million in 2024 and is forecast to a readjusted size of US$ 307 million by 2031 with a CAGR of 2.2% during the forecast period 2025-2031.
Published: 2025-02-14
Pages: 102
USD 3950.00 (Single User License)
Global Cosmetic Grade Nicotinamide Mononucleotide Market Insights, Forecast to 2030
Nicotinamide mononucleotides play an important role in the energy production of human cells by participating in the intracellular synthesis of NAD (nicotinamide adenine dinucleotide, an important coenzyme in cellular energy conversion). Nicotinamide mononucleotide, which was originally present in the human body but decreases with age. Earlier experiments have shown that nicotinamide mononucleotide NMN increases NAD in the organs of laboratory rats, thus inhibiting ageing of nerves and blood vessels, and also improving the symptoms of diabetes.
Published: 2024-04-14
Pages: 95
USD 4900.00 (Single User License)